Stock Updates

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) – Is this large market cap stock undervalued?

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), is firmly in the large market cap category with market cap of 29458.74. To be considered a large market cap stock companies have to be valued at more than $10 billion. The current price for Alexion Pharmaceuticals, Inc. is 132.96 (with a change from open of 1.03%), this in conjunction with a target price of 167.06. Volume today has so far reached 403944, with an average volume of about 1847.9. The GAP for this stock, is 0.11%.

The P/E ratio is 332.81, bringing the forward P/E to a value of 22.22. The current EPS for Alexion Pharmaceuticals, Inc., is 0.4, with a EPS growth for this year coming to a value of -79.50%. Performance has been interesting with performance year to date coming to -31.08%.

Looking further into the growth statistics for Alexion Pharmaceuticals, Inc., EPS is looking like it will grow 27.36% in the next year. Looking even further it is projected to be 18.28%. Quarter over quarter is -38.80% for EPS growth and for sales growth quarter over quarter it is 18.40%. Looking at past EPS growth statistics we see that for the past five years it has been 5.10%. Sales growth for the past five years has in fact been 36.90%.

Looking at the ownership, we see that the insider ownership is at 0.50% and institutional ownership is 98.30%. Shares outstanding is 224.09, while shares float is at a value of 223.42. Float short for Alexion Pharmaceuticals, Inc. is 2.26% and the short ratio is 2.73.

In terms of debt, long term debt/equity is 0.39, while the total debt/equity comes to 0.4. The ability to meet these debts, means that the current ratio is 3.6, and the quick ratio is 3.1. The most recent gross margin is 91.80% and their operating margin is 21.70%. The profit margin is 3.20%.

Alexion Pharmaceuticals, Inc. has seen returns on assets of 0.70%, and on investment, 1.60%. Return on equity is 1.10%. Price/Earnings to growth ratio is 18.2. Price/Sales ratio is at a value of 10.44, with Price/book ratio coming to 3.59 and Price/cash is 24.96, and finally Price/Free cash Flow is 54.68.

The simple moving averages are 2.49% and -7.97% for 20 day and 200 day simple moving average respectively. For the 52 week high and low the 52 week high is -31.27% and the 52 week low is 20.26%.

Alexion Pharmaceuticals, Inc. has a dividend yield of , with a current price of 132.96. The ability to pay this means the payout ratio is 0.00%. This is in an industry, Biotechnology, with equally high dividends from other companies in this sector, which it is Healthcare. Alexion Pharmaceuticals, Inc. is based in USA.

Performance in the Biotechnology industry means that Alexion Pharmaceuticals, Inc. has seen performance for the past week of 5.24%, with performance for the month coming to -1.20%. Looking at the data for the quarter it is at a value of 5.00%, and for the half year the performance is -21.75%. Volatility for this week is 3.29% and for the month this is 2.82%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment